• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IgM在基孔肯雅病毒早期感染过程中的中和作用。

The neutralizing role of IgM during early Chikungunya virus infection.

作者信息

Chua Chong-Long, Sam I-Ching, Chiam Chun-Wei, Chan Yoke-Fun

机构信息

Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

出版信息

PLoS One. 2017 Feb 9;12(2):e0171989. doi: 10.1371/journal.pone.0171989. eCollection 2017.

DOI:10.1371/journal.pone.0171989
PMID:28182795
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5300252/
Abstract

The antibody isotype IgM appears earlier than IgG, within days of onset of symptoms, and is important during the early stages of the adaptive immune response. Little is known about the functional role of IgM during infection with chikungunya virus (CHIKV), a recently reemerging arbovirus that has caused large global outbreaks. In this study, we studied antibody responses in 102 serum samples collected during CHIKV outbreaks in Malaysia. We described the neutralizing role of IgM at different times post-infection and examined the independent contributions of IgM and IgG towards the neutralizing capacity of human immune sera during the early phase of infection, including the differences in targets of neutralizing epitopes. Neutralizing IgM starts to appear as early as day 4 of symptoms, and their appearance from day 6 is associated with a reduction in viremia. IgM acts in a complementary manner with the early IgG, but plays the main neutralizing role up to a point between days 4 and 10 which varies between individuals. After this point, total neutralizing capacity is attributable almost entirely to the robust neutralizing IgG response. IgM preferentially binds and targets epitopes on the CHIKV surface E1-E2 glycoproteins, rather than individual E1 or E2. These findings provide insight into the early antibody responses to CHIKV, and have implications for design of diagnostic serological assays.

摘要

抗体同种型IgM在症状出现后的数天内比IgG更早出现,并且在适应性免疫反应的早期阶段很重要。关于IgM在基孔肯雅病毒(CHIKV)感染期间的功能作用知之甚少,CHIKV是一种最近重新出现的虫媒病毒,已在全球范围内引发大规模疫情。在本研究中,我们研究了在马来西亚CHIKV疫情期间收集的102份血清样本中的抗体反应。我们描述了感染后不同时间IgM的中和作用,并研究了在感染早期IgM和IgG对人免疫血清中和能力的独立贡献,包括中和表位靶点的差异。中和性IgM最早在症状出现后的第4天开始出现,从第6天开始出现与病毒血症的降低有关。IgM与早期IgG以互补方式起作用,但在第4天至第10天之间的某个时间点发挥主要中和作用,该时间点因人而异。在此之后,总的中和能力几乎完全归因于强大的中和性IgG反应。IgM优先结合并靶向CHIKV表面E1-E2糖蛋白上的表位,而不是单个E1或E2。这些发现为CHIKV的早期抗体反应提供了见解,并对诊断血清学检测的设计具有启示意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e836/5300252/ed983aacef24/pone.0171989.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e836/5300252/bcd945b7bfb7/pone.0171989.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e836/5300252/dacec21de16a/pone.0171989.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e836/5300252/ed983aacef24/pone.0171989.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e836/5300252/bcd945b7bfb7/pone.0171989.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e836/5300252/dacec21de16a/pone.0171989.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e836/5300252/ed983aacef24/pone.0171989.g003.jpg

相似文献

1
The neutralizing role of IgM during early Chikungunya virus infection.IgM在基孔肯雅病毒早期感染过程中的中和作用。
PLoS One. 2017 Feb 9;12(2):e0171989. doi: 10.1371/journal.pone.0171989. eCollection 2017.
2
A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis.一种靶向E2蛋白上N218表位的强效中和性IgM单克隆抗体可预防基孔肯雅病毒发病。
MAbs. 2015;7(6):1178-94. doi: 10.1080/19420862.2015.1083664. Epub 2015 Aug 25.
3
Antigenic Variation of East/Central/South African and Asian Chikungunya Virus Genotypes in Neutralization by Immune Sera.东非/中非/南非和亚洲基孔肯雅病毒基因型在免疫血清中和作用下的抗原变异
PLoS Negl Trop Dis. 2016 Aug 29;10(8):e0004960. doi: 10.1371/journal.pntd.0004960. eCollection 2016 Aug.
4
Anti-Chikungunya Virus Monoclonal Antibody That Inhibits Viral Fusion and Release.抗基孔肯雅病毒单克隆抗体抑制病毒融合和释放。
J Virol. 2020 Sep 15;94(19). doi: 10.1128/JVI.00252-20.
5
Chikungunya-specific IgG and neutralizing antibody responses in natural infection of Chikungunya virus in children from India.印度儿童自然感染基孔肯雅病毒的特异性 IgG 和中和抗体应答。
Arch Virol. 2021 Jul;166(7):1913-1920. doi: 10.1007/s00705-021-05049-3. Epub 2021 Apr 27.
6
Enzyme-linked immunosorbent assay using recombinant envelope protein 2 antigen for diagnosis of Chikungunya virus.采用重组包膜蛋白 2 抗原的酶联免疫吸附试验诊断基孔肯雅病毒。
Virol J. 2018 Jul 24;15(1):112. doi: 10.1186/s12985-018-1028-1.
7
Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy.基孔肯雅病毒包膜三聚体外侧表位残基的暴露决定抗体中和效力。
J Virol. 2014 Dec;88(24):14364-79. doi: 10.1128/JVI.01943-14. Epub 2014 Oct 1.
8
A small antigenic determinant of the Chikungunya virus E2 protein is sufficient to induce neutralizing antibodies which are partially protective in mice.基孔肯雅病毒E2蛋白的一个小抗原决定簇足以诱导产生中和抗体,这些抗体在小鼠中具有部分保护作用。
PLoS Negl Trop Dis. 2015 Apr 23;9(4):e0003684. doi: 10.1371/journal.pntd.0003684. eCollection 2015 Apr.
9
High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines.菲律宾一个前瞻性队列中基孔肯雅病毒亚临床感染的高发生率及中和抗体与保护作用的关联。
PLoS Negl Trop Dis. 2015 May 7;9(5):e0003764. doi: 10.1371/journal.pntd.0003764. eCollection 2015 May.
10
Unique epitopes recognized by antibodies induced in Chikungunya virus-infected non-human primates: implications for the study of immunopathology and vaccine development.感染基孔肯雅病毒的非人类灵长类动物体内诱导产生的抗体所识别的独特表位:对免疫病理学和疫苗开发研究的意义。
PLoS One. 2014 Apr 22;9(4):e95647. doi: 10.1371/journal.pone.0095647. eCollection 2014.

引用本文的文献

1
Pathogenesis and clinical management of arboviral diseases.虫媒病毒病的发病机制与临床管理
World J Virol. 2025 Mar 25;14(1):100489. doi: 10.5501/wjv.v14.i1.100489.
2
Activation of CXCR3 Tfh cells and B cells in lymph nodes during acute HIV-1 infection correlates with HIV-specific antibody development.急性HIV-1感染期间淋巴结中CXCR3辅助性滤泡T细胞和B细胞的激活与HIV特异性抗体的产生相关。
J Virol. 2025 Mar 18;99(3):e0153224. doi: 10.1128/jvi.01532-24. Epub 2025 Feb 11.
3
Receptor Binding Domain-Specific B Cell Memory Responses Among Individuals Vaccinated Against SARS-CoV-2.

本文引用的文献

1
Antigenic Variation of East/Central/South African and Asian Chikungunya Virus Genotypes in Neutralization by Immune Sera.东非/中非/南非和亚洲基孔肯雅病毒基因型在免疫血清中和作用下的抗原变异
PLoS Negl Trop Dis. 2016 Aug 29;10(8):e0004960. doi: 10.1371/journal.pntd.0004960. eCollection 2016 Aug.
2
Evaluation of Two Enzyme-Linked Immunosorbent Assay Kits for Chikungunya Virus IgM Using Samples from Deceased Organ and Tissue Donors.使用来自已故器官和组织捐赠者的样本对两种用于检测基孔肯雅病毒IgM的酶联免疫吸附测定试剂盒进行评估。
Clin Vaccine Immunol. 2016 Oct 4;23(10):825-830. doi: 10.1128/CVI.00330-16. Print 2016 Oct.
3
接种 SARS-CoV-2 疫苗个体中的受体结合域特异性 B 细胞记忆反应。
Vaccines (Basel). 2024 Dec 12;12(12):1396. doi: 10.3390/vaccines12121396.
4
A safe insect-based chikungunya fever vaccine affords rapid and durable protection in cynomolgus macaques.一种安全的基于昆虫的基孔肯雅热疫苗在食蟹猕猴中提供快速且持久的保护。
NPJ Vaccines. 2024 Dec 19;9(1):251. doi: 10.1038/s41541-024-01047-z.
5
Pathogenicity and virulence of chikungunya virus.基孔肯雅病毒的致病性和毒力。
Virulence. 2024 Dec;15(1):2396484. doi: 10.1080/21505594.2024.2396484. Epub 2024 Sep 1.
6
Cryptic circulation of chikungunya virus in São Jose do Rio Preto, Brazil, 2015-2019.2015-2019 年巴西圣若泽-里波朗德州基孔肯雅热病毒的隐匿性循环。
PLoS Negl Trop Dis. 2024 Mar 14;18(3):e0012013. doi: 10.1371/journal.pntd.0012013. eCollection 2024 Mar.
7
Cytokine profile, neutralisation potential and viral replication dynamics in sera of chikungunya patients in India: a cross-sectional study.印度基孔肯雅热患者血清中的细胞因子谱、中和潜力及病毒复制动态:一项横断面研究
Lancet Reg Health Southeast Asia. 2023 Sep 1;19:100269. doi: 10.1016/j.lansea.2023.100269. eCollection 2023 Dec.
8
Chikungunya virus antepartum transmission and abnormal infant outcomes in a cohort of pregnant women in Nigeria.尼日利亚孕妇队列中寨卡病毒的产前传播和婴儿异常结局。
Int J Infect Dis. 2024 Feb;139:92-100. doi: 10.1016/j.ijid.2023.11.036. Epub 2023 Dec 4.
9
Serological and Molecular Epidemiology of Chikungunya Virus Infection in Vietnam, 2017-2019.2017-2019 年越南基孔肯雅热病毒感染的血清学和分子流行病学。
Viruses. 2023 Oct 8;15(10):2065. doi: 10.3390/v15102065.
10
Influence of host genetic polymorphisms involved in immune response and their role in the development of Chikungunya disease: a review.宿主免疫反应相关遗传多态性及其在基孔肯雅热发病机制中的作用:综述。
Braz J Med Biol Res. 2023 Sep 8;56:e12557. doi: 10.1590/1414-431X2023e12557. eCollection 2023.
Pathogenic Chikungunya Virus Evades B Cell Responses to Establish Persistence.
致病性基孔肯雅病毒逃避B细胞反应以建立持续性感染。
Cell Rep. 2016 Aug 2;16(5):1326-1338. doi: 10.1016/j.celrep.2016.06.076. Epub 2016 Jul 21.
4
Unmet Needs for a Rapid Diagnosis of Chikungunya Virus Infection.基孔肯雅病毒感染快速诊断的未满足需求。
Emerg Infect Dis. 2016 Oct;22(10):1837-9. doi: 10.3201/eid2210.151784. Epub 2016 Oct 15.
5
Expression and Purification of E2 Glycoprotein from Insect Cells (Sf9) for Use in Serology.用于血清学检测的昆虫细胞(Sf9)中E2糖蛋白的表达与纯化
Methods Mol Biol. 2016;1426:51-61. doi: 10.1007/978-1-4939-3618-2_5.
6
Early clearance of Chikungunya virus in children is associated with a strong innate immune response.儿童基孔肯雅病毒的早期清除与强烈的先天免疫反应有关。
Sci Rep. 2016 May 16;6:26097. doi: 10.1038/srep26097.
7
Evaluation of Commercially Available Chikungunya Virus Immunoglobulin M Detection Assays.市售基孔肯雅病毒免疫球蛋白M检测方法的评估
Am J Trop Med Hyg. 2016 Jul 6;95(1):182-192. doi: 10.4269/ajtmh.16-0013. Epub 2016 Mar 14.
8
Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress.广谱中和性甲病毒抗体结合 E2 上的一个表位,并抑制进入和离开。
Cell. 2015 Nov 19;163(5):1095-1107. doi: 10.1016/j.cell.2015.10.050. Epub 2015 Nov 6.
9
Utilization of an Eilat Virus-Based Chimera for Serological Detection of Chikungunya Infection.利用基于埃拉特病毒的嵌合体进行基孔肯雅热感染的血清学检测。
PLoS Negl Trop Dis. 2015 Oct 22;9(10):e0004119. doi: 10.1371/journal.pntd.0004119. eCollection 2015.
10
A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis.一种靶向E2蛋白上N218表位的强效中和性IgM单克隆抗体可预防基孔肯雅病毒发病。
MAbs. 2015;7(6):1178-94. doi: 10.1080/19420862.2015.1083664. Epub 2015 Aug 25.